Skip to main content

Table 3 LF, PFS, and OS in total and depending on time

From: Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases

 

LF

PFS

OS

Event (progress/death) - absolute/(%)

7 (20.6)

25 (80.6)

17 (54.8)

No event - absolute/(%)

27 (79.4)

6 (19.4)

14 (45.2)

Time (in months)

mean: 79.0

median: 2.3

median: 18.7

95%-CI (in months)

53.6–104.3

1.0–3.6

8.1–29.2

 

Proportion surviving after

 

6-months

12-months

18-months

24-months

OS

80%

64%

50%

34%

PFS

30%

19%

15%

15%

 

Probability of LF after

 

6-months

12-months

18-months

24-months

LF

6%

26%

26%

26%

  1. LF local failure, PFS progression-free survival, OS overall survival, CI confidence interval